ATC |
Anatomical Therapeutic Chemical (ATC) classification system |
BHA |
Butylated hydroxyanisole |
BHT |
Butylated hydroxytoluene |
COVID-19 |
Coronavirus disease 2019 |
DNA |
Deoxyribonucleic Acid |
DSL |
Domestic Substance List |
EDTA |
Ethylenediamine tetra acetate |
EMA |
European Medicines Agency |
FEMA |
Flavor and Extract Manufacturers Association |
FDA |
The US Food and Drug Administration |
GRAS |
Generally Recognized as Safe |
HDL |
High-density lipoprotein |
IL-1β |
member of the Interleukin-1 family |
IARC |
International Agency for Cancer Research |
I.P. |
Intraperitoneal injection |
IUPAC |
International Union of Pure and Applied Chemistry |
I.V. |
Intravenous medication administration |
LD50
|
50% Lethal dose |
LDL |
Low-density lipoprotein |
NAD |
Nicotinamide adenine dinucleotide, oxidized form |
NADH |
Nicotinamide adenine dinucleotide, reduced form |
NRF2 |
Nuclear factor erythroid 2-Related Factor 2 |
PEG |
Propylene glycol |
PG |
Propyl gallate |
RNS |
Reactive nitrogen species |
ROS |
Reactive oxygen species |
SARS-CoV-2 |
Severe acute respiratory syndrome coronavirus 2 |
SOD |
Superoxide dismutase |
TDLo
|
Toxic Dose Low (the lowest toxic dose) |
THBQ |
t-Butyl hydroquinone |
TNF |
Tumor necrosis factor |
UNII |
Unique ingredient identifiers, generated by the joint FDA/USP Substance Registration System |
WHO |
World Health Organization |